| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |